bisbenzimidazole has been researched along with Myocardial Infarction in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frantz, S | 1 |
| Ducharme, A | 1 |
| Sawyer, D | 1 |
| Rohde, LE | 1 |
| Kobzik, L | 1 |
| Fukazawa, R | 1 |
| Tracey, D | 1 |
| Allen, H | 1 |
| Lee, RT | 1 |
| Kelly, RA | 1 |
1 other study available for bisbenzimidazole and Myocardial Infarction
| Article | Year |
|---|---|
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction.
Topics: Animals; Apoptosis; Bisbenzimidazole; Blotting, Northern; Blotting, Western; Caspase 1; Collagen; Co | 2003 |